Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Beyfortus Granted Approval in China for Preventing RSV Disease in Infants
Tuesday, January 02, 2024AstraZeneca and Sanofi have obtained approval from Chinas National Medical Products Administration NMPA for their longacting monoclonal antibody Beyfortus as a preventive measure against respiratory syncytial virus
Positive Outcomes Revealed in Interim Analysis of REC610, Recbio's Innovative Adjuvanted Recombinant Shingles Vaccine Clinical Trial in the Philippines
Friday, December 29, 2023Jiangsu Recbio Technology Co Ltd is thrilled to report positive results from the interim analysis of the firstinhuman clinical trial conducted in the Philippines for its novel adjuvanted recombinant shingles vaccine
Innovent and Xuanzhu Partner on Sintilimab Combination Trial for Advanced Solid Tumors in China
Thursday, December 28, 2023Innovent Biologics Inc and Xuanzhu Biopharma have recently disclosed a partnership involving a clinical trial and supply agreement for exploring combination therapies of sintilimab injection
Biocytogen and CtM Bio Make Noteworthy Progress in Collaborative Development of TCR-Mimic Antibody-Based Multi-Specific T Cell Engager Targeting WT1/HLA-A02
Thursday, December 28, 2023Biocytogen Pharmaceuticals Co Ltd and CtM Biotech Co Ltd have reported significant advancements in the development of a trispecific T cell engager targeting an intracellular protein
Everest Medicines Has Received Approval for the New Drug Application (NDA) for Nefecon® in Taiwan, Aimed at Treating Primary IGA Nephropathy in Adult Patients
Wednesday, December 27, 2023Everest Medicines has declared that the Taiwan Food and Drug Administration has accepted its New Drug Application for Nefecon for the treatment of primary immunoglobulin A nephropathy
LianBio Enters into an Agreement Transferring Rights for NBTXR3 in China and Other Asian Markets
Tuesday, December 26, 2023LianBio a biotechnology company dedicated to introducing innovative medicines to patients in China and other significant Asian markets has announced a recent agreement with Janssen Pharmaceutica NV
FDA Approves Label Revision for BRUKINSA® (zanubrutinib) in Chronic Lymphocytic Leukemia (CLL)
Saturday, December 23, 2023BeiGene Ltd has received approval from the US Food and Drug Administration for a label update for BRUKINSA zanubrutinib This update is based on superior progressionfree survival
CStone Transfers Its Exclusive Rights for TIBSOVO® to Servier in Greater China and Singapore
Friday, December 22, 2023CStone Pharmaceuticals and Servier a global pharmaceutical group have recently announced a collaborative agreement This agreement entails Servier acquiring exclusive rights to develop
ImPact Biotech Secures FDA Approval for IND Application of Padeliporfin VTP in Pancreatic Cancer
Thursday, December 21, 2023ImPact Biotech a clinicalstage biotechnology company has received clearance from the US Food and Drug Administration for its Investigational New Drug application
Ono and EVQLV Collaborate to Utilize AI-Powered Antibody Design for the Development of Novel Antibody Drugs Against Multiple Targets
Wednesday, December 20, 2023Ono Pharmaceutical Co Ltd headquartered in Osaka Japan led by President and CEO Gyo Sagara has recently announced a collaborative partnership with EVQLV INC
